ClinicalTrials.gg
WithdrawnNCT06504667Updated Jun 30, 2026

To Validate Point Mini User Needs

An interventional study of Point Mini in Amputation; Traumatic, Hand and Amputation, Congenital, sponsored by Point Designs. Withdrawn at 2 sites in United States. Open to participants aged 5 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Point Designs · Not applicable, Interventional, and Device feasibility

How we know

Why this study was withdrawn
Early termination of funding

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
5 Years to 15 Years
Sex
All
01

Study summary

The objective of the device feasibility study will be to validate the user needs of the Point Mini system. This study will be a single group intervention model where one group of 5 children with partial-hand upper limb loss will be asked to perform several tasks. Successful completion of a task results in a fulfilled user need. Failure to complete a task results in an unfulfilled user need.

02

Conditions studied

  • Amputation; Traumatic, Hand
  • Amputation, Congenital
03

In context

Lead sponsor

Point Designs is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 5 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Partial hand loss with at least index and/or middle fingers loss at the MCP level
  • Intact thumb with full range of motion
  • Fluent in English
  • Between the ages of 5 and 15 years

Exclusion criteria

Exclusion Criteria:

  • Patients with a residual limb that is unhealed from the amputation surgery
  • Unhealed wounds
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems as judged by the project therapist
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Prosthesis

    Patient is temporarily fit with Point Mini finger prosthetic system

    Device: Point Mini

Interventions

  • DevicePoint Mini

    The Point Mini finger prosthetic system consists of 1-4 ratcheting mechanical digits and mounting brackets

06

What researchers measure

Primary outcomes

  1. VAL-1

    User wears Point Mini(s) for a entire session without discomfort (Pass/Fail)

    Time frame: Day 1 (8 hours)

  2. VAL-2

    User flexes and extends the Point Mini(s) without using contralateral hand ten times (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  3. VAL-3.1

    User lifts a 10-25 lb bag with Point Mini(s) depending on age (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  4. VAL-3.2

    User grips a hammer with Point Mini(s) and makes indentations into the wood (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  5. VAL-4

    User releases Point Mini(s) while performing an active grasp by pressing the dorsal button ten times sequentially (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  6. VAL-5

    User positions Point Mini(s) into each of the locking positions without binding (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  7. VAL-6

    User activates spring-back mechanism ten times without failure by using (1) contralateral hand, (2) tabletop, and (3) side or thigh (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  8. VAL-7

    User grips a 5 lb cylindrical smooth object using Point Mini(s) for 10 seconds (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  9. VAL-8

    User picks up 4 coins from a smooth tabletop within 30 seconds (Pass/Fail)

    Time frame: Day 1 (10 minutes)

  10. VAL-9

    User performs VAL-1 through VAL-8 without Point Mini releasing from mounting system (Pass/Fail)

    Time frame: Day 1 (8 hours)

07

Study locations

2 sites
  • University of Colorado Denver | Anschutz Medical Campus
    Aurora, Colorado 80045, United States
  • Point Designs
    Lafayette, Colorado 80026, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2025 to primary completion in Jul 2025, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2024
First posted
Jul 17, 2024
StartActual
Jul 29, 2025
Primary completionActual
Jul 29, 2025
CompletionActual
Jul 29, 2025
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06504667
Lead sponsor
Point Designs
Responsible party
Sponsor
First posted
Jul 17, 2024
Start date
Jul 29, 2025
Primary completion
Jul 29, 2025
Completion
Jul 29, 2025
Last update
Jun 30, 2026

Study contacts

Levin Sliker, PhD
principal investigator · CEO, Point Designs

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion